In NSCLC, IL-6 induces TGFβ-mediated EMT through the IL-6/Janus kinase (JAK)/STAT signaling pathway, thereby enhancing metastatic potential via activation of nuclear factor kappa-B (NF-κB) signaling [15]. The gene discussed is SOAT1; the disease is non-small cell lung carcinoma.